Impact of sepsis on levels of plasma cystatin C in AKI and non-AKI patients

Nephrology Dialysis Transplantation

Volumn 27, Issue 2, 2012, Pages 576-581

  Mrtensson, Johan ^a   Martling, Claes Roland ^a   Oldner, Anders ^a   Bell, Max ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

acute kidney injury; acute renal failure; biomarkers; creatinine; cystatin C

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; CREATININE; CYSTATIN C;

ACUTE KIDNEY FAILURE; ADULT; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SEPSIS;

ACUTE KIDNEY INJURY; ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BIOLOGICAL MARKERS; BODY WEIGHT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; CREATININE; CRITICAL ILLNESS; CYSTATIN C; DISEASE PROGRESSION; FEMALE; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEPSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 84856825675     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr358     Document Type: Article

References (28)

1. Bell M, Granath F, Schon S et al. Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure. Intensive Care Med 2007; 33: 773-780
2. Uchino S, Kellum JA, Bellomo R et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294: 813-818
3. Parikh CR, Devarajan P. New biomarkers of acute kidney injury. Crit Care Med 2008; 36 (4 Suppl): S159-S165
4. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 221-226
5. Mussap M, Dalla Vestra M, Fioretto P et al. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 2002; 61: 1453-1461
6. Coll E, Botey A, Alvarez L et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000; 36: 29-34
7. Herget-Rosenthal S, Marggraf G, Husing J et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004; 66: 1115-1122
8. Nejat M, Pickering JW, Walker RJ et al. Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrol Dial Transplant 2010; 25: 3283-3289
9. Royakkers AA, Korevaar JC, van Suijlen JD et al. Serum. and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. Intensive Care Med 2011; 37: 493-501
10. Perianayagam MC, Seabra VF, Tighiouart H et al. Serum cystatin C for prediction of dialysis requirement or death in acute kidney injury: a comparative study. Am J Kidney Dis 2009; 54: 1025-1033
11. Knight EL, Verhave JC, Spiegelman D et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65: 1416-1421
12. Stevens LA, Schmid CH, Greene T et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009; 75: 652-660
13. Martensson J, Bell M, Oldner A et al. Neutrophil. gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 2010; 36: 1333-1340
14. Nejat M, Pickering JW, Walker RJ et al. Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Crit Care 2010; 14: R85
15. Bagshaw SM, George C, Bellomo R. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care 2008; 12: R47
16. Bellomo R, Ronco C, Kellum JA et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212
17. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655
18. Bernard GR, Vincent JL, Laterre PF et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709
19. Bell M, Granath F, Martensson J et al. Cystatin. C is correlated with mortality in patients with and without acute kidney injury. Nephrol Dial Transplant 2009; 24: 3096-3102
20. Grubb A, Bjork J, Nyman U et al. Cystatin. C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation. Scand J Clin Lab Invest 2011; 71: 145-149
21. Assfalg-Machleidt I, Jochum M, Nast-Kolb D et al. Cathepsin B-indicator for the release of lysosomal cysteine proteinases in severe trauma and inflammation. Biol Chem Hoppe-Seyler 1990; 371 (Suppl): 211-222
22. Farges MC, Balcerzak D, Fisher BD et al. Increased muscle proteolysis after local trauma mainly reflects macrophage-associated lysosomal proteolysis. Am J Physiol Endocrinol Metab 2002; 282: E326-E335
23. Kortebein P, Ferrando A, Lombeida J et al. Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA 2007; 297: 1772-1774
24. Finn PJ, Plank LD, Clark MA et al. Progressive cellular dehydration and proteolysis in critically ill patients. Lancet 1996; 347: 654-656
25. Mehta RL, McDonald B, Gabbai F et al. Nephrology consultation in acute renal failure: does timing matter? Am J Med 2002; 113: 456-461
26. Risch L, Herklotz R, Blumberg A et al. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 2001; 47: 2055-2059
27. Poge U, Gerhardt T, Bokenkamp A et al. Time course of low molecular weight proteins in the early kidney transplantation period-influence of corticosteroids. Nephrol Dial Transplant 2004; 19: 2858-2863
28. Bokenkamp A, Laarman CA, Braam KI et al. Effect of corticosteroid therapy on low-molecular weight protein markers of kidney function. Clin Chem 2007; 53: 2219-2221